VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 703 filers reported holding VANECK VECTORS ETF TR in Q2 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,456,832 | -11.1% | 128,459 | -0.5% | 0.00% | 0.0% |
Q2 2023 | $3,886,418 | -20.1% | 129,074 | -14.1% | 0.00% | 0.0% |
Q1 2023 | $4,862,561 | +14.1% | 150,311 | +1.1% | 0.00% | 0.0% |
Q4 2022 | $4,261,340 | +19.0% | 148,686 | +0.2% | 0.00% | 0.0% |
Q3 2022 | $3,580,000 | -11.1% | 148,435 | +0.9% | 0.00% | 0.0% |
Q2 2022 | $4,026,000 | -28.7% | 147,061 | -0.1% | 0.00% | 0.0% |
Q1 2022 | $5,644,000 | +19.9% | 147,161 | +0.1% | 0.00% | 0.0% |
Q4 2021 | $4,708,000 | +6.7% | 146,991 | -1.8% | 0.00% | 0.0% |
Q3 2021 | $4,413,000 | -13.3% | 149,749 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $5,088,000 | -3.7% | 149,749 | -7.8% | 0.00% | 0.0% |
Q1 2021 | $5,282,000 | -10.6% | 162,504 | -0.9% | 0.00% | -33.3% |
Q4 2020 | $5,909,000 | -7.7% | 164,042 | +0.3% | 0.00% | 0.0% |
Q3 2020 | $6,403,000 | +171.9% | 163,494 | +189.9% | 0.00% | +200.0% |
Q2 2020 | $2,355,000 | +11114.3% | 56,400 | +5964.5% | 0.00% | – |
Q1 2019 | $21,000 | – | 930 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Harbor Financial Group, LLC | 2,418,400 | $77,461,000 | 26.62% |
Brevan Howard Capital Management LP | 1,000,000 | $32,030,000 | 23.21% |
Windmill Hill Asset Management Ltd | 844,600 | $27,053,000 | 19.48% |
Memorial Sloan Kettering Cancer Center | 738,500 | $23,654,000 | 14.86% |
New Harbor Financial Group, LLC | 1,286,391 | $41,203,000 | 14.16% |
Eschler Asset Management LLP | 300,000 | $9,609,000 | 12.30% |
Hollow Brook Wealth Management LLC | 712,669 | $22,827,000 | 11.71% |
Grand Central Investment Group | 284,547 | $9,114,000 | 10.90% |
Baymount Management LP | 500,000 | $16,015,000 | 9.54% |
Nokomis Capital, L.L.C. | 512,628 | $16,419,000 | 6.93% |